Excellent results and minimal complications of total hip arthroplasty in sickle cell hemoglobinopathy at mid-term follow-up using cementless prosthetic components

Journal of Arthroplasty

Volumn 28, Issue 9, 2013, Pages 1693-1698

  Issa, Kimona ^a   Naziri, Qais ^a,b   Maheshwari, Aditya V ^b   Rasquinha, Vijay J ^b   Delanois, Ronald E ^a   Mont, Michael A ^a  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Clinical outcomes; Harris hip scores; Implant survivorship; Sickle cell hemoglobinopathy; Total hip arthroplasty

Indexed keywords

ADULT; ARTICLE; BONE NECROSIS; CEMENTLESS PROSTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HARRIS HIP SCORE; HIP RADIOGRAPHY; HUMAN; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PROSTHESIS INFECTION; REOPERATION; SEPSIS; SHORT FORM 36; SICKLE CELL ANEMIA; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME;

CLINICAL OUTCOMES; HARRIS HIP SCORES; IMPLANT SURVIVORSHIP; SICKLE CELL HEMOGLOBINOPATHY; TOTAL HIP ARTHROPLASTY;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ARTHROPLASTY, REPLACEMENT, HIP; FOLLOW-UP STUDIES; HIP PROSTHESIS; HUMANS; MIDDLE AGED; OSTEONECROSIS; YOUNG ADULT;

EID: 84885022675     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2013.03.017     Document Type: Article

References (40)

1. Rees D.C., Williams T.N., Gladwin M.T. Sickle-cell disease. Lancet 2010, 376(9757):2018.
2. Chung S.M., Ralston E.L. Necrosis of the femoral head associated with sickle-cell anemia and its genetic variants. A review of the literature and study of thirteen cases. J Bone Joint Surg Am 1969, 51(1):33.
3. Milner P.F., Kraus A.P., Sebes J.I., et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med 1991, 325(21):1476.
4. Chung S.M., Alavi A., Russell M.O. Management of osteonecrosis in sickle-cell anemia and its genetic variants. Clin Orthop Relat Res 1978, 130:158.
5. Hernigou P., Bachir D., Galacteros F. The natural history of symptomatic osteonecrosis in adults with sickle-cell disease. J Bone Joint Surg Am 2003, 85-A(3):500.
6. Hernigou P., Habibi A., Bachir D., et al. The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease. J Bone Joint Surg Am 2006, 88(12):2565.
7. Mont M.A., Zywiel M.G., Marker D.R., et al. The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review. J Bone Joint Surg Am 2010, 92(12):2165.
8. Mont M.A., Seyler T.M., Plate J.F., et al. Uncemented total hip arthroplasty in young adults with osteonecrosis of the femoral head: a comparative study. J Bone Joint Surg Am 2006, 88(Suppl 3):104.
9. Hungerford D.S. Treatment of osteonecrosis of the femoral head: everything's new. J Arthroplasty 2007, 22(4 Suppl 1):91.
10. Mont M.A., Seyler T.M., Marker D.R., et al. Use of metal-on-metal total hip resurfacing for the treatment of osteonecrosis of the femoral head. J Bone Joint Surg Am 2006, 88(Suppl 3):90.
11. Acurio M.T., Friedman R.J. Hip arthroplasty in patients with sickle-cell haemoglobinopathy. J Bone Joint Surg Br 1992, 74(3):367.
12. Bishop A.R., Roberson J.R., Eckman J.R., et al. Total hip arthroplasty in patients who have sickle-cell hemoglobinopathy. J Bone Joint Surg Am 1988, 70(6):853.
13. Clarke H.J., Jinnah R.H., Brooker A.F., et al. Total replacement of the hip for avascular necrosis in sickle cell disease. J Bone Joint Surg Br 1989, 71(3):465.
14. Gunderson C., D'Ambrosia R.D., Shoji H. Total hip replacement in patients with sickle-cell disease. J Bone Joint Surg Am 1977, 59(6):760.
15. Hanker G.J., Amstutz H.C. Osteonecrosis of the hip in the sickle-cell diseases. Treatment and complications. J Bone Joint Surg Am 1988, 70(4):499.
16. Moran M.C., Huo M.H., Garvin K.L., et al. Total hip arthroplasty in sickle cell hemoglobinopathy. Clin Orthop Relat Res 1993, 294:140.
17. Hickman J.M., Lachiewicz P.F. Results and complications of total hip arthroplasties in patients with sickle-cell hemoglobinopathies. Role of cementless components. J Arthroplasty 1997, 12(4):420.
18. Ilyas I., Moreau P. Simultaneous bilateral total hip arthroplasty in sickle cell disease. J Arthroplasty 2002, 17(4):441.
19. Sanjay B.K., Moreau P.G. Bipolar hip replacement in sickle cell disease. Int Orthop 1996, 20(4):222.
20. Steinberg M.H. Management of sickle cell disease. N Engl J Med 1999, 340(13):1021.
21. Stuart M.J., Nagel R.L. Sickle-cell disease. Lancet 2004, 364(9442):1343.
22. Platt O.S., Brambilla D.J., Rosse W.F., et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994, 330(23):1639.
23. Hammer M., Geier K.A., Aksoy S., et al. Perioperative care for patients with sickle cell who are undergoing total hip replacement as treatment for osteonecrosis. Orthop Nurs 2003, 22(6):384.
24. Marulanda G.A., Minniti C.P., Ulrich S.D., et al. Perioperative management for orthopaedic patients with sickle cell anaemia. J Orthop Surg (Hong Kong) 2009, 17(3):346.
25. dos Santos J.L., Lanaro C., Chin C.M. Advances in sickle cell disease treatment: from drug discovery until the patient monitoring. Cardiovasc Hematol Agents Med Chem 2011, 9(2):113.
26. Friedrich M.J. Advances reshaping sickle cell therapy. JAMA 2011, 305(3):239.
27. Inati A. Recent advances in improving the management of sickle cell disease. Blood Rev 2009, 23(Suppl 1):S9.
28. Ibrahim S.A., Siminoff L.A., Burant C.J., et al. Understanding ethnic differences in the utilization of joint replacement for osteoarthritis: the role of patient-level factors. Med Care 2002, 40(1 Suppl):I44.
29. Allen Butler R., Rosenzweig S., Myers L., et al. The Frank Stinchfield Award: the impact of socioeconomic factors on outcome after THA: a prospective, randomized study. Clin Orthop Relat Res 2011, 469(2):339.
30. Lavernia C.J., Lee D., Sierra R.J., et al. Race, ethnicity, insurance coverage, and preoperative status of hip and knee surgical patients. J Arthroplasty 2004, 19(8):978.
31. Groeneveld P.W., Kwoh C.K., Mor M.K., et al. Racial differences in expectations of joint replacement surgery outcomes. Arthritis Rheum 2008, 59(5):730.
32. Johannson H.R., Zywiel M.G., Marker D.R., et al. Osteonecrosis is not a predictor of poor outcomes in primary total hip arthroplasty: a systematic literature review. Int Orthop 2011, 35(4):465.
33. Arlet J., Ficat P. Non-traumatic avascular femur head necrosis. New methods of examination and new concepts. Chir Narzadow Ruchu Ortop Pol 1977, 42(3):269.
34. Specifications Manual for National Hospital Inpatient Quality Measures. http://www.jointcommission.org/specifications_manual_for_national_hospital_inpatient_quality_measures.aspx.
35. Parvizi J., Zmistowski B., Berbari E.F., et al. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res 2011, 469(11):2992.
36. Harris W.H. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am 1969, 51(4):737.
37. Nietert P.J., Silverstein M.D., Abboud M.R. Sickle cell anaemia: epidemiology and cost of illness. Pharmacoeconomics 2002, 20(6):357.
38. Hernigou P., Zilber S., Filippini P., et al. Total THA in adult osteonecrosis related to sickle cell disease. Clin Orthop Relat Res 2008, 466(2):300.
39. Al-Mousawi F., Malki A., Al-Aradi A., et al. Total hip replacement in sickle cell disease. Int Orthop 2002, 26(3):157.
40. Jeong G.K., Ruchelsman D.E., Jazrawi L.M., et al. Total hip arthroplasty in sickle cell hemoglobinopathies. J Am Acad Orthop Surg 2005, 13(3):208.